Recombinant Elastase Inhibitors for Therapy
- 1 May 1991
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 624 (1) , 212-218
- https://doi.org/10.1111/j.1749-6632.1991.tb17020.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Pharmacokinetics and Distribution of Recombinant Secretory Leukocyte Proteinase Inhibitor in RatsAmerican Review of Respiratory Disease, 1990
- Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.Journal of Clinical Investigation, 1989
- Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.Proceedings of the National Academy of Sciences, 1989
- Kinetic Studies on the Interaction of Eglincwith Human Leukocyte Elastase and Cathepsin GBiological Chemistry Hoppe-Seyler, 1987
- Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin CarlsbergFEBS Letters, 1985
- Beneficial effects of a neutral protease inhibitor in traumatic shockPharmacological Research Communications, 1985
- Complete sequence of the cDNA for human .alpha.1-antitrypsin and the gene for the S variantBiochemistry, 1984
- Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- [60] Eglin: Elastase—Cathepsin G inhibitor from leechesPublished by Elsevier ,1981
- Isolation and Characterisation of a Low Molecular Weight Inhibitor (of Chymotrypsin and Human Granulocytic Elastase and Cathepsin G) from LeechesHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1976